Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4

CTLA-4 Control over Foxp3 + Regulatory T Cell Function

Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T., & Sakaguchi, S. (2008) · Science · doi:10.1126/science.1160062 · Cited by 2,956

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914

Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4

Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766

Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation

Read, S., Malmström, V., & Powrie, F. M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.295 · Cited by 2,206

Plat-E: an efficient and stable system for transient packaging of retroviruses

MORITA, S., Kojima, T., & Kitamura, T. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301206 · Cited by 1,660

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies

Peggs, K. S., Quezada, S. A., Chambers, C. A., Korman, A. J., & Allison, J. P. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082492 · Cited by 967

CD28 and CTLA-4 coreceptor expression and signal transduction

Rudd, C. E., Taylor, A., & Schneider, H. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00770.x · Cited by 898

Foxp3 + natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation

Onishi, Y., Fehervari, Z. T., Yamaguchi, T., & Sakaguchi, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711106105 · Cited by 754

B cells acquire antigen from target cells after synapse formation

Batista, F. D., Iber, D., & Neuberger, M. S. (2001) · Nature · doi:10.1038/35078099 · Cited by 629

A MOLECULAR PERSPECTIVE OF CTLA-4 FUNCTION

Teft, W. A., Kirchhof, M. G., & Madrenas, J. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090535 · Cited by 526

Regulatory T cell-derived extracellular vesicles modify dendritic cell function

Tung, S. L., Boardman, D. A., Sen, M., Letizia, M., Peng, Q., Cianci, N., Dioni, L., Carlin, L. M., Lechler, R. I., Bollati, V., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-24531-8 · Cited by 254

Molecular and Cellular Functions of CTLA-4

Coillie, S. V., Wiernicki, B., & Xu, J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-3266-5_2 · Cited by 259

Combined PARP Inhibition and Immune Checkpoint Therapy in Solid Tumors

Peyraud, F., & Italiano, A. (2020) · Cancers · doi:10.3390/cancers12061502 · Cited by 245

Regulatory T Cells: the Many Faces of Foxp3

Georgiev, P., Charbonnier, L., & Chatila, T. A. (2019) · Journal of Clinical Immunology · doi:10.1007/s10875-019-00684-7 · Cited by 253

The Role Of PD-1/PD-L1 Axis In Treg Development And Function: Implications For Cancer Immunotherapy

Cai, J., Wang, D., Zhang, G., & Guo, X. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s221340 · Cited by 251

Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects

Jia, H., Truica, C. I., Wang, B., Wang, Y., Ren, X., Harvey, H. A., Song, J. J., & Yang, J. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.07.002 · Cited by 246

The intersection of radiotherapy and immunotherapy: Mechanisms and clinical implications

Spiotto, M. T., Fu, Y., & Weichselbaum, R. R. (2016) · Science Immunology · doi:10.1126/sciimmunol.aag1266 · Cited by 241

Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction

Bauer, C. A., Kim, E. Y., Marangoni, F., Carrizosa, E., Claudio, N., & Mempel, T. R. (2014) · Journal of Clinical Investigation · doi:10.1172/jci66375 · Cited by 246

Two modes of immune suppression by Foxp3+ regulatory T cells under inflammatory or non-inflammatory conditions

Yamaguchi, T., Wing, J. B., & Sakaguchi, S. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.10.002 · Cited by 240

Treg-mediated acquired resistance to immune checkpoint inhibitors

Saleh, R., & Elkord, E. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.05.003 · Cited by 242

Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood

Klocke, K., Sakaguchi, S., Holmdahl, R., & Wing, K. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603892113 · Cited by 234

Regulatory T cells in autoimmune neuroinflammation

Kleinewietfeld, M., & Hafler, D. A. (2014) · Immunological Reviews · doi:10.1111/imr.12169 · Cited by 238

Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology

Selby, M., Engelhardt, J., Johnston, R. J., Lu, L.-S., Han, M., Thudium, K. B., Yao, D., Quigley, M. M., Valle, J., Wang, C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161779 · Cited by 236

Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma

Fan, J., Wang, M., Chen, H., Shang, D., Das, J. K., & Song, J. J. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01151-3 · Cited by 230

Targeting co-stimulatory molecules in autoimmune disease

Edner, N. M., Carlesso, G., Rush, J. S., & Walker, L. S. K. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0081-9 · Cited by 232

Targeting regulatory T cells in tumors

Liu, C., Workman, C. J., & Vignali, D. A. A. (2016) · The FEBS Journal · doi:10.1111/febs.13656 · Cited by 228

The Complex Role of Regulatory T Cells in Immunity and Aging

Rocamora‐Reverte, L., Melzer, F. L., Würzner, R., & Weinberger, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.616949 · Cited by 239

Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation

Kennedy, A., Waters, E., Rowshanravan, B., Hinze, C., Williams, C., Janman, D., Fox, T. A., Booth, C., Pesenacker, A. M., Halliday, N., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01289-w · Cited by 227

The multifaceted immune regulation of bladder cancer

Schneider, A. K., Chevalier, M. F., & Derré, L. (2019) · Nature Reviews Urology · doi:10.1038/s41585-019-0226-y · Cited by 222

A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity

Kumar, P., Bhattacharya, P., & Prabhakar, B. S. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.08.007 · Cited by 222

Treg cells in health and autoimmune diseases: New insights from single cell analysis

Scheinecker, C., Göschl, L., & Bonelli, M. M. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102376 · Cited by 224

Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity

Paterson, A. M., Lovitch, S. B., Sage, P. T., Juneja, V. R., Lee, Y., Trombley, J. D., Arancibia-Cárcamo, C. V., Sobel, R. A., Rudensky, A. Y., Kuchroo, V. K., et al. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20141030 · Cited by 220

Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection

Penaloza‐MacMaster, P., Kamphorst, A. O., Wieland, A., Araki, K., Iyer, S. S., West, E. E., O’Mara, L. A., Yang, S., Konieczny, B. T., Sharpe, A. H., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20132577 · Cited by 211

Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody

Ha, D., Tanaka, A., Kibayashi, T., Tanemura, A., Sugiyama, D., Wing, J. B., Lim, E. L., Teng, K. W. W., Adeegbe, D., Newell, E. W., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812186116 · Cited by 205

Control of Regulatory T Cell Migration, Function, and Homeostasis

Campbell, D. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500801 · Cited by 218

Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action

Willsmore, Z. N., Coumbe, B. G. T., Crescioli, S., Reci, S., Gupta, A., Harris, R. J. C., Chenoweth, A. M., Chauhan, J., Bax, H. J., McCraw, A. J., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202048747 · Cited by 216

A Genome-Wide Association Study of Myasthenia Gravis

Renton, A. E., Pliner, H. A., Provenzano, C., Evoli, A., Ricciardi, R., Nalls, M. A., Marangi, G., Abramzon, Y. A., Arepalli, S., Chong, S., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.4103 · Cited by 206

New insights into the T cell synapse from single molecule techniques

Dustin, M. L., & Depoil, D. (2011) · Nature reviews. Immunology · doi:10.1038/nri3066 · Cited by 205

Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop

Marangoni, F., Zhakyp, A., Corsini, M., Geels, S. N., Carrizosa, E., Thelen, M., Mani, V., Pruessmann, J. N., Warner, R. D., Ozga, A. J., et al. (2021) · Cell · doi:10.1016/j.cell.2021.05.027 · Cited by 209

Regulatory T Cells: Regulation of Identity and Function

Grover, P., Goel, P. N., & Greene, M. I. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.750542 · Cited by 223

Availability of 25-Hydroxyvitamin D3 to APCs Controls the Balance between Regulatory and Inflammatory T Cell Responses

Jeffery, L. E., Wood, A. M., Qureshi, O. S., Hou, T. Z., Gardner, D. H., Briggs, Z., Kaur, S., Raza, K., & Sansom, D. M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200786 · Cited by 203

Detection of self-reactive CD8 + T cells with an anergic phenotype in healthy individuals

Maeda, Y., Nishikawa, H., Sugiyama, D., Ha, D., Hamaguchi, M., Saito, T., Nishioka, M., Wing, J. B., Adeegbe, D. O., Katayama, I., et al. (2014) · Science · doi:10.1126/science.aaa1292 · Cited by 202

T cell exhaustion: from pathophysiological basics to tumor immunotherapy

Catakovic, K., Klieser, E., Neureiter, D., & Geisberger, R. (2017) · Cell Communication and Signaling · doi:10.1186/s12964-016-0160-z · Cited by 207

Adaptive immunity in atherogenesis: new insights and therapeutic approaches

Lichtman, A. H., Binder, C. J., Tsimikas, S., & Witztum, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci63108 · Cited by 201

Immunomodulators targeting the PD‐1/PD‐L1 protein‐protein interaction: From antibodies to small molecules

Yang, J., & Hu, L. (2018) · Medicinal Research Reviews · doi:10.1002/med.21530 · Cited by 201

Tregs: Where We Are and What Comes Next?

Hai, Z., Liao, X., & Kang, Y. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01578 · Cited by 200

Regulatory T Cells: Barriers of Immune Infiltration Into the Tumor Microenvironment

Scott, E. N., Gocher, A. M., Workman, C. J., & Vignali, D. A. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.702726 · Cited by 200

Immune disease risk variants regulate gene expression dynamics during CD4+ T cell activation

Soskic, B., Cano-Gamez, E., Smyth, D. J., Ambridge, K., Ke, Z., Matte, J. C., Bossini‐Castillo, L., Kaplanis, J., Ramirez-Navarro, L., Lorenc, A., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01066-3 · Cited by 204

Regulation of Treg cells by cytokine signaling and co-stimulatory molecules

Zong, Y., Deng, K., & Chong, W. P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1387975 · Cited by 202

Exploiting CTLA-4, PD-1 and PD-L1 to reactivate the host immune response against cancer

Quezada, S. A., & Peggs, K. S. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.117 · Cited by 192

Modulation of regulatory T cell function and stability by co-inhibitory receptors

Lucca, L. E., & Dominguez‐Villar, M. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-0296-3 · Cited by 197

Control of regulatory T‐cell differentiation and function by T‐cell receptor signalling and Foxp3 transcription factor complexes

Ono, M. (2020) · Immunology · doi:10.1111/imm.13178 · Cited by 187

Suppressing T cell motility induced by anti–CTLA-4 monotherapy improves antitumor effects

Ruocco, M. G., Pilones, K. A., Kawashima, N., Cammer, M., Huang, J. H. Y., Babb, J. S., Liu, M., Formenti, S. C., Dustin, M. L., & Demaria, S. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61931 · Cited by 187

Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells

Agarwal, S., Aznar, M. A., Rech, A. J., Good, C. R., Kuramitsu, S., Da, T., Gohil, M., Chen, L., Hong, S.-J. A., Ravikumar, P., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.09.001 · Cited by 199

Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1+ Activated T Cells

Dovedi, S. J., Elder, M. J., Yang, C., Sitnikova, S. I., Irving, L., Hansen, A., Hair, J., Jones, D. C., Hasani, S., Wang, B., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1445 · Cited by 186

Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation

Wing, K., Yamaguchi, T., & Sakaguchi, S. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.06.002 · Cited by 188

Unique human immune signature of Ebola virus disease in Guinea

Ruibal, P., Oestereich, L., Lüdtke, A., Becker‐Ziaja, B., Wozniak, D. M., Kerber, R., Korva, M., Cabeza-Cabrerizo, M., Boré, J. A., Koundouno, F. R., et al. (2016) · Nature · doi:10.1038/nature17949 · Cited by 182

CTLA-4 controls follicular helper T-cell differentiation by regulating the strength of CD28 engagement

Wang, C. J., Heuts, F. W. H., Ovcinnikovs, V., Wardzinski, L., Bowers, C., Schmidt, E. M., Kogimtzis, A., Kenefeck, R., Sansom, D. M., & Walker, L. S. K. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414576112 · Cited by 184

Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options

Kabacaoğlu, D., Ciecielski, K. J., Ruess, D. A., & Algül, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01878 · Cited by 181

Critical role of the gut microbiota in immune responses and cancer immunotherapy

Li, Z., Xiong, W., Zhu, L. W., Wang, J., Zeng, Z., Kołat, D., Li, X., Zhou, D., Xu, X., & Zhao, L.-Y. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01541-w · Cited by 197

Cytotoxic T lymphocyte antigen-4 and immune checkpoint blockade

Buchbinder, E. L., & Hodi, F. S. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80012 · Cited by 181

What did we learn from CTLA ‐4 insufficiency on the human immune system?

Mitsuiki, N., Schwab, C., & Grimbacher, B. (2018) · Immunological Reviews · doi:10.1111/imr.12721 · Cited by 187

Genetic and epigenetic basis of Treg cell development and function: from a FoxP3‐centered view to an epigenome‐defined view of natural Treg cells

Morikawa, H., & Sakaguchi, S. (2014) · Immunological Reviews · doi:10.1111/imr.12174 · Cited by 176

In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment

Vanpouille‐Box, C., Pilones, K. A., Wennerberg, E., Formenti, S. C., & Demaria, S. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.05.105 · Cited by 180

CTLA-4 Is Expressed by Activated Mouse NK Cells and Inhibits NK Cell IFN-γ Production in Response to Mature Dendritic Cells

Stojanovic, A., Fiegler, N., Brunner-Weinzierl, M. C., & Cerwenka, A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302091 · Cited by 181

Development of immune checkpoint therapy for cancer

Fritz, J. M., & Lenardo, M. J. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20182395 · Cited by 179

Current Advances in the Treatment of BRAF-Mutant Melanoma

Patel, H. M., Yacoub, N., Mishra, R., White, A., Yuan, L., Alanazi, S., & Garrett, J. T. (2020) · Cancers · doi:10.3390/cancers12020482 · Cited by 184

The link between circulating follicular helper T cells and autoimmunity

Walker, L. S. K. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00693-5 · Cited by 182

Constitutive Clathrin-mediated Endocytosis of CTLA-4 Persists during T Cell Activation

Qureshi, O., Kaur, S., Hou, T. Z., Jeffery, L. E., Poulter, N. S., Briggs, Z., Kenefeck, R., Willox, A. K., Royle, S., Rappoport, J. Z., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.304329 · Cited by 172

Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials

Niu, Z., Jin, R., Zhang, Y., & Li, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01200-x · Cited by 185

Mechanisms of action of therapeutic antibodies for cancer

Redman, J. M., Hill, E., Aldeghaither, D. S., & Weiner, L. M. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.04.002 · Cited by 179

Regulatory T-Cells at the Interface between Human Host and Pathogens in Infectious Diseases and Vaccination

Boer, M. C., Joosten, S. A., & Ottenhoff, T. H. M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00217 · Cited by 170

The Transcription Factor NFAT Exhibits Signal Memory during Serial T Cell Interactions with Antigen-Presenting Cells

Marangoni, F., Murooka, T. T., Manzo, T., Kim, E. Y., Carrizosa, E., Elpek, N. M., & Mempel, T. R. (2013) · Immunity · doi:10.1016/j.immuni.2012.09.012 · Cited by 169

Multiple treg suppressive modules and their adaptability

Wing, J. B., & Sakaguchi, S. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00178 · Cited by 169

Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy

Liu, Y., & Zheng, P. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.11.003 · Cited by 163

Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab

Ramagopal, U. A., Liu, W., Garrett-Thomson, S. C., Bonanno, J. B., Yan, Q., Srinivasan, M., Wong, S. C., Bell, A., Mankikar, S., Rangan, V. S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617941114 · Cited by 170

Regulatory T-cell therapy in Crohn’s disease: challenges and advances

Clough, J., Omer, O. S., Tasker, S., Lord, G. M., & Irving, P. M. (2020) · Gut · doi:10.1136/gutjnl-2019-319850 · Cited by 168

Foxp3 Post-translational Modifications and Treg Suppressive Activity

Deng, G., Song, X., Fujimoto, S., Piccirillo, C. A., Nagai, Y., & Greene, M. I. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02486 · Cited by 171

Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: The next frontier

Esensten, J. H., Müller, Y. D., Bluestone, J. A., & Tang, Q. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.10.015 · Cited by 162

Natural and Induced Tolerogenic Dendritic Cells

Iberg, C. A., & Hawiger, D. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901121 · Cited by 166

Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer

Zagorulya, M., Yim, L., Morgan, D. M., Edwards, A. W., Torres-Mejia, E., Momin, N., McCreery, C. V., Zamora, I., Horton, B. L., Fox, J. G., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.01.010 · Cited by 160

CTLA-4–mediated transendocytosis of costimulatory molecules primarily targets migratory dendritic cells

Ovcinnikovs, V., Ross, E. M., Petersone, L., Edner, N. M., Heuts, F. W. H., Ntavli, E., Kogimtzis, A., Kennedy, A., Wang, C. J., Bennett, C. L., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aaw0902 · Cited by 158

Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine

Kumagai, S., Itahashi, K., & Nishikawa, H. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00870-6 · Cited by 171

Lymph node – an organ for T‐cell activation and pathogen defense

Gasteiger, G., Ataide, M. A., & Kastenmüller, W. (2016) · Immunological Reviews · doi:10.1111/imr.12399 · Cited by 155

CHAI and LATAIE: new genetic diseases of CTLA-4 checkpoint insufficiency

Lo, B., Fritz, J. M., Su, H. C., Uzel, G., Jordan, M. B., & Lenardo, M. J. (2016) · Blood · doi:10.1182/blood-2016-04-712612 · Cited by 155

Role of Regulatory T Cells in Regulating Fetal-Maternal Immune Tolerance in Healthy Pregnancies and Reproductive Diseases

Huang, N., Chi, H., & Qiao, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01023 · Cited by 174

Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?

Hilkens, C. M. U., & Isaacs, J. D. (2012) · Clinical & Experimental Immunology · doi:10.1111/cei.12038 · Cited by 158

CTLA-4 and PD-1 Control of T-Cell Motility and Migration: Implications for Tumor Immunotherapy

Brunner-Weinzierl, M. C., & Rudd, C. E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02737 · Cited by 156

Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions

Arruga, F., Gyau, B. B., Iannello, A., Vitale, N., Vaisitti, T., & Deaglio, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051825 · Cited by 160

Inhibitory receptors as targets for cancer immunotherapy

Turnis, M. E., Andrews, L. P., & Vignali, D. A. A. (2015) · European Journal of Immunology · doi:10.1002/eji.201344413 · Cited by 157

Foxp3+ T Regulatory Cells: Still Many Unanswered Questions—A Perspective After 20 Years of Study

Shevach, E. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01048 · Cited by 157

mTOR Signaling, Tregs and Immune Modulation

Chapman, N. M., & Chi, H. (2014) · Immunotherapy · doi:10.2217/imt.14.84 · Cited by 148

Not All Immune Checkpoints Are Created Equal

Linhares, A. D. S., Leitner, J. M., Grabmeier‐Pfistershammer, K., & Steinberger, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01909 · Cited by 157

Regulatory T Cells in Cancer

Plitas, G., & Rudensky, A. Y. (2020) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033428 · Cited by 148

CTLA-4, an Essential Immune-Checkpoint for T-Cell Activation

Chikuma, S. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_61 · Cited by 155

A local regulatory T cell feedback circuit maintains immune homeostasis by pruning self-activated T cells

Wong, H. S., Park, K., Gola, A., Baptista, A. P., Miller, C. H., Deep, D., Lou, M., Boyd, L. F., Rudensky, A. Y., Savage, P. A., et al. (2021) · Cell · doi:10.1016/j.cell.2021.05.028 · Cited by 152

Hematologic complications of immune checkpoint inhibitors

Kroll, M. H., Hernandez, C. M. R., & Yee, C. (2021) · Blood · doi:10.1182/blood.2020009016 · Cited by 153

Tissue-specific Tregs in cancer metastasis: opportunities for precision immunotherapy

Huppert, L. A., Green, M. D., Kim, L., Chow, C., Leyfman, Y., DAUD, A. I., & Lee, J. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00742-4 · Cited by 150

Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer

Wang, Y., Wang, Y., Ren, Y., Zhang, Q., Yi, P., & Cheng, C. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.010 · Cited by 148

Dysfunction of antigen processing and presentation by dendritic cells in cancer

Bandola-Simon, J. M., & Roche, P. A. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.03.025 · Cited by 142

Exhaustion of T lymphocytes in the tumor microenvironment: Significance and effective mechanisms

Gholami, M. D., Kardar, G. A., Saeedi, Y., Heidari, S., Garssen, J., & Falak, R. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.10.002 · Cited by 143

Natural Killer Cells in Cancer Immunotherapy

Miller, J. S., & Lanier, L. L. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055653 · Cited by 145

Tregopathies: Monogenic diseases resulting in regulatory T-cell deficiency

Cepika, A., Sato, Y., Liu, J. M.-H., Uyeda, M. J., Bacchetta, R., & Roncarolo, M. G. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.10.026 · Cited by 147

CTLA-4 and autoimmunity: New insights into the dual regulator of tolerance

Romo‐Tena, J., Gómez‐Martín, D., & Alcocer-Varela, J. C. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.07.002 · Cited by 138

Regulatory T cells impede acute and long-term immunity to blood-stage malaria through CTLA-4

Kurup, S. P., Obeng-Adjei, N., Anthony, S. M., Traoré, B., Doumbo, O. K., Butler, N. S., Crompton, P. D., & Harty, J. T. (2017) · Nature Medicine · doi:10.1038/nm.4395 · Cited by 140

Biological Functions of Regulatory T Cells

Shevach, E. M. (2011) · Advances in immunology · doi:10.1016/b978-0-12-387827-4.00004-8 · Cited by 137

Targeting immune checkpoints in hematological malignancies

Salik, B., Smyth, M. J., & Nakamura, K. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00947-6 · Cited by 113

Protein kinase C-η controls CTLA-4–mediated regulatory T cell function

Kong, K., Fu, G., Zhang, Y., Yokosuka, T., Casas, J., Canonigo-Balancio, A. J., Bécart, S., Kim, G., Yates, J. R., Kronenberg, M., et al. (2014) · Nature Immunology · doi:10.1038/ni.2866 · Cited by 139

Immune deficiency and autoimmunity in patients with CTLA-4 (CD152) mutations

Verma, N., Burns, S. O., Walker, L. S. K., & Sansom, D. M. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.12997 · Cited by 136

Reinvigorating exhausted CD8 + cytotoxic T lymphocytes in the tumor microenvironment and current strategies in cancer immunotherapy

Hossain, M. A., Liu, G., Dai, B., Si, Y., Yang, Q., Wazir, J., Birnbaumer, L., & Yang, Y. (2020) · Medicinal Research Reviews · doi:10.1002/med.21727 · Cited by 138

CTLA-4-mediated trans-endocytosis in the control of T cell co-stimulation

Ovcinnikovs, V. (2018) · UCL Discovery (University College London)

Investigating transendocytosis mediated by CTLA4

Nguyen, L. (2023) · UNSWorks (University of New South Wales, Sydney, Australia) · doi:10.26190/unsworks/24962

CTLA4 depletes T cell endogenous and trogocytosed B7 ligands via cis-endocytosis

Xu, X., Dennett, P., Zhang, J., Sherrard, A., Zhao, Y., Masubuchi, T., Bui, J. D., Chen, X., & Hui, E. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20221391 · Cited by 56

Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation

Kennedy, A., Waters, E., Rowshanravan, B., Hinze, C., Williams, C., Janman, D., Fox, T. A., Booth, C., Pesenacker, A. M., Halliday, N., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01289-w · Cited by 227

Molecular and Cellular Functions of CTLA-4

Coillie, S. V., Wiernicki, B., & Xu, J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-3266-5_2 · Cited by 259